King Bio Recalls Safecare+ AllergyCare Oral Spray Due to Microbial Contamination
King Bio Inc. is recalling Safecare+ AllergyCare Homeopathic Non-Drowsy Taste-Free Oral Spray due to microbial contamination. The product was distributed in the U.S., Canada, and Australia.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class I, which mandates a minimum severity score of 4 per the rubric.
Plain-English summary
King Bio Inc. is recalling 492 bottles of Safecare+ AllergyCare Homeopathic Non-Drowsy Taste-Free, Oral Spray, 1 fl oz (29.6 mL). The recall is due to microbial contamination. The affected product has UPC 357955404316 and NDC 57955-4043-1.
The recalled lots are 021717E (Expiration 02/20) and 091015R (Expiration 09/18). The product was distributed nationwide in the U.S.A., as well as in Canada and Australia.
Consumers should stop using the product and contact King Bio Inc. for further instructions or a refund.
The recalled product
- Product
- Safecare+ AllergyCare Homeopathic Non-Drowsy Taste-Free, Oral Spray, 1 fl oz (29.6 mL), UPC 357955404316, NDC 57955-4043-1
- Manufacturer
- King Bio Inc.
- Category
- Drug — Homeopathic
- Hazard
- Affected units
- 492
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lots: 021717E Exp. 02/20
- 091015R Exp. 09/18
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 465 recalled by King Bio Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 465 products in this recall →Related recalls
Same manufacturer · King Bio Inc.
See all →- CriticalKing Bio Recalls Dr. King's SafeCare Rx Calloused Due to Microbial Contamination
FDA (Drugs) · 2019-03-20
- SevereKing Bio Homeopathic Allergy Spray Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
- CriticalKing Bio Recalls Heartburn Relief for Microbial Contamination
FDA (Drugs) · 2019-03-20
- SevereKing Bio Homeopathic Allergy Product Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
- CriticalDr. King's Advanced Arnica Recalled for Microbial Contamination
FDA (Drugs) · 2019-03-20
Same hazard · microbial contamination
See all →- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- HighSV Labs Recalls Benzoyl Peroxide Wash Due to Microbial Contamination
FDA (Drugs) · 2026-10-07
- SevereMedline Ultrasound Breast Pack Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- HighMedline Convenience Kits Recalled for Potential Sterility Breach
FDA (Devices) · 2026-09-09
- CriticalOptimal Balance Pharmacy Recalls Contaminated Glutathione Injection Vials
FDA (Drugs) · 2026-09-09
Similar recalls
- HighSprayology Recalls AllergEase Homeopathic Oral Spray Due to CGMP Deviations
FDA (Drugs) · 2018-11-07
- ModerateSprayology Recalls Rejuvenation Plus Homeopathic Oral Spray Due to CGMP Deviations
FDA (Drugs) · 2018-11-07
- HighSprayology Recalls Cold + Flu Relief Homeopathic Oral Spray
FDA (Drugs) · 2018-11-07
- ModerateSprayology Recalls Stress Relief Homeopathic Oral Spray Due to CGMP Deviations
FDA (Drugs) · 2018-11-07
- SevereSilver Star Brands Recalls DizziFree Oral Spray Due to CGMP Deviations
FDA (Drugs) · 2018-11-14
- SevereSprayology Recalls Acne Tonic Homeopathic Oral Spray Due to CGMP Deviations
FDA (Drugs) · 2018-11-07